Back
Day Range
$39.17
$41.67
52-Week Range
$5.49
$42.88
Volume
550,931
50D / 200D Avg
$34.01
/
$23.79
Prev Close
$38.91
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -14.8 | 0.4 |
| P/B | 3.3 | 2.9 |
| ROE % | -24.7 | 3.8 |
| Net Margin % | — | 3.9 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.0 | 0.2 |
Key Takeaways
Debt/Equity of 0.00 — conservative balance sheet
Negative free cash flow of -88.42M
PEG of 0.24 suggests growth is underpriced
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-24.69%
ROIC-19.32%
Net MarginN/A
Op. MarginN/A
Safety
Debt / Equity
0.00
Current Ratio22.37
Interest Coverage0.00
Valuation
P/E Ratio
-14.76
P/B Ratio3.30
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0.0 | Net Income (TTM) | -105.43M |
| ROE | -24.69% | ROA | -21.58% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -88.42M |
| ROIC | -19.32% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.00 | Current Ratio | 22.37 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -14.76 | P/B Ratio | 3.30 |
| P/S Ratio | N/A | PEG Ratio | 0.24 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 1.56B | Enterprise Value | 1.51B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | -105.43M | -83.72M | -5.34M | -9.93M | -19.32M |
| EPS (Diluted) | -2.31 | -4.99 | -4.44 | -8.27 | -16.68 |
| Gross Profit | -83,000.0 | -27,000.0 | -111,000.0 | -114,000.0 | -91,000.0 |
| Operating Income | -122.05M | -88.12M | -7.30M | -9.84M | -19.34M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 488.62M | 396.02M | 37.86M | 43.09M | 54.92M |
| Total Liabilities | 16.69M | 13.80M | 841,000.0 | 1.41M | 3.88M |
| Shareholders' Equity | 471.93M | 382.22M | 37.02M | 41.67M | 51.04M |
| Total Debt | 1.93M | 968,000.0 | 280,000.0 | 383,000.0 | 483,000.0 |
| Cash & Equivalents | 46.94M | 61.58M | 37.43M | 42.45M | 53.36M |
| Current Assets | 343.86M | 376.87M | 37.59M | 42.70M | 54.42M |
| Current Liabilities | 15.37M | 13.04M | 637,000.0 | 1.13M | 3.50M |